hexamethylene bisacetamide has been researched along with Experimental Mammary Neoplasms in 2 studies
N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have been studying the role of Hexamethylene bisacetamide (HMBA) Induced Protein 1 (HEXIM1) as a tumor suppressor whose expression is decreased in tamoxifen resistant and metastatic breast cancer." | 3.83 | Induction of HEXIM1 activities by HMBA derivative 4a1: Functional consequences and mechanism. ( Exner, A; Ketchart, W; Lathia, J; Montano, MM; Reizes, O; Su, B; Thiagarajan, PS; Yeh, IJ; Zhou, H, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ketchart, W | 1 |
| Yeh, IJ | 1 |
| Zhou, H | 1 |
| Thiagarajan, PS | 1 |
| Lathia, J | 1 |
| Reizes, O | 1 |
| Exner, A | 1 |
| Su, B | 1 |
| Montano, MM | 1 |
| Chun, HG | 1 |
| Leyland-Jones, B | 1 |
| Hoth, D | 1 |
| Shoemaker, D | 1 |
| Wolpert-DeFilippes, M | 1 |
| Grieshaber, C | 1 |
| Cradock, J | 1 |
| Davignon, P | 1 |
| Moon, R | 1 |
| Rifkind, R | 1 |
1 review available for hexamethylene bisacetamide and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Hexamethylene bisacetamide: a polar-planar compound entering clinical trials as a differentiating agent.
Topics: Acetamides; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cell Line | 1986 |
1 other study available for hexamethylene bisacetamide and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Induction of HEXIM1 activities by HMBA derivative 4a1: Functional consequences and mechanism.
Topics: Acetamides; Animals; Antigens, Polyomavirus Transforming; Antineoplastic Agents; Benzeneacetamides; | 2016 |